213 related articles for article (PubMed ID: 29161793)
1. Effect of Rifaximin on Hepatic Fibrosis in Bile Duct-ligated Rat Model.
Shin SK; Kwon OS; Lee JJ; Park YH; Choi CS; Jeong SH; Choi DJ; Kim YS; Kim JH
Korean J Gastroenterol; 2017 Nov; 70(5):239-246. PubMed ID: 29161793
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
3. Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.
Wu L; Zhou PQ; Xie JW; Zhu R; Zhou SC; Wang G; Wu ZX; Hao S
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):519-524. PubMed ID: 26223920
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
Kim MY; Baik SK; Park DH; Jang YO; Suk KT; Yea CJ; Lee IY; Kim JW; Kim HS; Kwon SO; Cho MY; Ko SB; Chang SJ; Um SH; Han KH
J Gastroenterol; 2008; 43(11):889-96. PubMed ID: 19012043
[TBL] [Abstract][Full Text] [Related]
5. Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: a biochemical and immunohistochemical approach.
Oztürk H; Yağmur Y; Buyukbayram H; Dokucu AI; Gurel A
Eur Surg Res; 2002; 34(4):285-90. PubMed ID: 12145554
[TBL] [Abstract][Full Text] [Related]
6. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P
United European Gastroenterol J; 2020 Dec; 8(10):1174-1185. PubMed ID: 32878579
[TBL] [Abstract][Full Text] [Related]
7. Time course of collagen peak in bile duct-ligated rats.
Tarcin O; Basaranoglu M; Tahan V; Tahan G; Sücüllü I; Yilmaz N; Sood G; Snyder N; Hilman G; Celikel C; Tözün N
BMC Gastroenterol; 2011 Apr; 11():45. PubMed ID: 21527001
[TBL] [Abstract][Full Text] [Related]
8. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
[TBL] [Abstract][Full Text] [Related]
9. CGX, a multiple herbal drug, improves cholestatic liver fibrosis in a bile duct ligation-induced rat model.
Kim HG; Han JM; Lee HW; Lee JS; Son SW; Choi MK; Lee DS; Wang JH; Son CG
J Ethnopharmacol; 2013 Jan; 145(2):653-62. PubMed ID: 23228913
[TBL] [Abstract][Full Text] [Related]
10. Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats.
Toklu HZ; Dumlu MU; Sehirli O; Ercan F; Gedik N; Gökmen V; Sener G
J Pharm Pharmacol; 2007 Sep; 59(9):1287-95. PubMed ID: 17939210
[TBL] [Abstract][Full Text] [Related]
11. Aqueous extract of Artemisia iwayomogi Kitamura attenuates cholestatic liver fibrosis in a rat model of bile duct ligation.
Han JM; Kim HG; Choi MK; Lee JS; Park HJ; Wang JH; Lee JS; Son SW; Hwang SY; Son CG
Food Chem Toxicol; 2012 Oct; 50(10):3505-13. PubMed ID: 22824087
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats.
Lim JH; Kim TW; Song IB; Park SJ; Kim MS; Cho ES; Jung JY; Son HY; Kim JW; Yun HI
Hum Exp Toxicol; 2013 Nov; 32(11):1197-205. PubMed ID: 23424213
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
14. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
[TBL] [Abstract][Full Text] [Related]
15. Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats.
Oztürk H; Oztürk H; Dokucu AI; Otcu S
Acta Gastroenterol Belg; 2006; 69(2):197-202. PubMed ID: 16929615
[TBL] [Abstract][Full Text] [Related]
16. Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats.
Tahan G; Akin H; Aydogan F; Ramadan SS; Yapicier O; Tarcin O; Uzun H; Tahan V; Zengin K
Can J Surg; 2010 Oct; 53(5):313-8. PubMed ID: 20858375
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.
Moal F; Veal N; Vuillemin E; Barrière E; Wang J; Fizanne L; Oberti F; Douay O; Gallois Y; Bonnefont-Rousselot D; Rousselet MC; Calès P
World J Gastroenterol; 2006 Nov; 12(41):6639-45. PubMed ID: 17075977
[TBL] [Abstract][Full Text] [Related]
18. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
[TBL] [Abstract][Full Text] [Related]
19. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ
J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats.
Jiao K; Sun Q; Chen B; Li S; Lu J
Scand J Gastroenterol; 2014 Jun; 49(6):715-21. PubMed ID: 24742111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
